Survey - AVITHRAPID project AVITHRAPID is a European flagship project co-funded by the European Commission and the Swiss Confederation, dedicated to accelerating antiviral innovation and strengthening Europe’s preparedness for future epidemics and pandemics. This survey explores how society perceives pandemics and future preparedness.

Last week to participate! 🚨
Science isn’t just labs-it’s people. Help AVITHRAPID prioritize the research that protects our future. Be the expert of your own experience and help steer European antiviral R&D. 🧬

👉 avithrapid.eu/survey/

#AVITHRAPID

Reflecting on the anniversary of the COVID-19 pandemic declaration.

The #AVITHRAPID project is working to build "ready-to-use" antiviral platforms. Our goal? To identify and accelerate treatments for emerging viruses so we can respond to future threats in weeks, not years.

From reactive to proactive: the market for global pandemic defense is changing. 📈

Stay ahead of the curve with the #AVITHRAPID newsletter. Get the latest insights on antiviral research and health security trends directly from our experts.

Join us here: 👉

🌍 Are we prepared for the next pandemic?

Discover insights on global pandemic preparedness and the future of proactive defense in our latest report.

📩 Subscribe to our newsletter to download it: avithrapid.eu/newsle...


#AVITHRAPID #GlobalHealth #PandemicPreparedness #Antivirals

Survey - AVITHRAPID project AVITHRAPID is a European flagship project co-funded by the European Commission and the Swiss Confederation, dedicated to accelerating antiviral innovation and strengthening Europe’s preparedness for future epidemics and pandemics. This survey explores how society perceives pandemics and future preparedness.

avithrapid.eu/survey/

#AVITHRAPID launches its international #PublicOpinionSurvey to understand how #pandemicspreparedness, and antiviral research are perceived by society.

Your voice matters in building a more prepared and resilient future.

Survey - AVITHRAPID project AVITHRAPID is a European flagship project co-funded by the European Commission and the Swiss Confederation, dedicated to accelerating antiviral innovation and strengthening Europe’s preparedness for future epidemics and pandemics. This survey explores how society perceives pandemics and future preparedness.

avithrapid.eu/survey/

#AVITHRAPID launches its international #PublicOpinionSurvey to understand how #pandemicspreparedness, and antiviral research are perceived by society.

Your voice matters in building a more prepared and resilient future.

2025 was a key year for #AVITHRAPID 🚀
From strengthening European collaborations to advancing antiviral research and knowledge sharing, we worked together to improve #pandemicpreparedness and #globalhealth resilience.

Thank you to all partners - onward to 2026!

Universal Health Coverage Day.
Preparedness is part of universal health.

AVITHRAPID contributes by advancing antiviral research and strengthening future response capacities.

#AVITHRAPID #GlobalHealth

Epidemic = local surge.
Pandemic = global spread.

Severity isn’t what defines a pandemic - reach does.
COVID-19 proved how fast that jump can happen.

#AVITHRAPID #Preparedness

At SC25 (Nov 2025, St. Louis), @it4innovations.bsky.social showcased AVITHRAPID - highlighting how high-performance computing fuels the next generation of antiviral research.
Thank you, IT4Innovations!
#AVITHRAPID #SC25 #HPC #Research

Targeting the virus is not enough.
AVITHRAPID explores host-directed antivirals, reducing resistance and enabling broad-spectrum preparedness.
Innovation for future pandemics.

🔗 avithrapid.eu/newsle...

#AVITHRAPID #AntiviralResearch

🌐 AVITHRAPID Project Portal - your gateway to antiviral R&D and pandemic preparedness.

🔗 Discover more: avithrapid.eu/projec...

#AVITHRAPID #InnovationGateway #AntiviralResearch #Preparedness"

AVITHRAPID evolves! 🧬
A new Training section is now live on our website - open to everyone interested in infectious diseases, small molecules, and AI-driven antiviral discovery.
🔗 Explore it here: avithrapid.eu/training/
#AVITHRAPID #ScienceEducation #AI #DrugDiscovery

Small molecules are a flexible and scalable tool for new and resistant viruses.

AVITHRAPID puts them at the core of our antiviral strategy.

#Antivirals #Innovation #AVITHRAPID

European Researchers' Night at Frascati Scienza - AVITHRAPID project Frascati Scienza celebrated 20 years of science, passion, and curiosity with the 2025 edition of the European Researchers’ Night. The event filled squares, schools, museums, and institutions throughout Italy with a week packed with events dedicated to scientific dissemination: a journey through STEAM – Science, Technology, Engineering, Art, and Mathematics – culminating on September 26, 2025, with the European Researchers’ Night. The European Researchers’ Night was the opportunity to introduce the AVITHRAPID project to the research community and the general public. It brought its results to researchers closer to the public, attracting over 30.000 visitors to all events, while increasing the interest of young people in science and research careers and showing how researchers’ work affects our daily lives. Francesca Ceccherini Silberstein with her team from University of Rome Tor Vergata distributed and illustrated some dissemination material prepared for this specific event. Poster

avithrapid.eu/europe...

At the end of September, Frascati Scienza celebrated 20 years of science during the European Researchers’ Night 2025 🇪🇺
Through Tor Vergata University, AVITHRAPID engaged with the public, sharing advances in antiviral research.
#AVITHRAPID #ERN2025 #ScienceOutreach

🟢Today, APPEAL was showcased in the #AVITHRAPID seminar series, marking the first step towards exploring synergies between the two #HorizonEU funded projects.

A big thank you to the AVITHRAPID consortium for the kind invitation and for hosting such an inspiring and productive event!

Small molecules are key to the future of antivirals: fast to develop, easy to deliver, globally accessible.

At AVITHRAPID, we put them at the core of our mission to protect against emerging viruses.

#AVITHRAPID #Antivirals #DrugDiscovery

💊 Small molecules = game-changer for antivirals.

Where is their biggest impact?
- Emerging viral threats
- Resistant strains
- Global access
- Other / not sure

Vote & share your view in the comments!

#AVITHRAPID #Antivirals #DrugDiscovery #Biotech

AVITHRAPID will be at the European Researchers’ Night on 26 Sept in Italy 🇮🇹.
Our scientists will share how small molecules and advanced research shape the future of antivirals.
#AVITHRAPID #ERN2025 #Innovation

AVITHRAPID will be part of Settimana della Scienza in Italy (20–27 Sept) 🇮🇹 through our partner Tor Vergata University.
At their stand, you can learn more about our mission and the future of antiviral drug discovery.

Program: www.frascatiscienza....

#AVITHRAPID #ScienceWeek #ERN2025

AI is changing healthcare 🚀

But when it comes to drug discovery, which impact do you see first?
- Speed of development
- Personalized therapies
- Cost savings
- Still unclear

Cast your vote ⬇️

#AVITHRAPID #Innovation #DrugDiscovery

AVITHRAPID and Area Science Park Join Forces to Drive Antiviral Innovation - AVITHRAPID project AVITHRAPID has signed a new Memorandum of Understanding (MoU) with Area Science Park, a leading Italian research hub, to accelerate innovation in antiviral therapeutics and preventive strategies. This agreement marks a significant step forward in strengthening Europe’s ability to anticipate, prevent, and respond to future infectious disease threats. At its core lies a shared ambition: […]

AVITHRAPID and Area Science Park just published an annoucement about their new partnership to drive antiviral and preventive innovation.
The MoU strengthens Europe’s scientific response to future health threats.
📰 Read more: avithrapid.eu/avithr...
#AVITHRAPID #ScienceFeed #PublicHealth #Innovation

AVITHRAPID is advancing broad-spectrum antivirals across Europe — and we’re sharing it with you.

Subscribe to our newsletter for updates on research, events, partnerships & more.
📩 avithrapid.eu/newsle...
#AVITHRAPID #ScienceFeed #PublicHealth

AVITHRAPID has signed an MoU with @AREASciencePark to strengthen Europe’s preparedness for future pandemics.
The partnership will boost rapid antiviral development, training, funding strategy & long-term impact.

#AVITHRAPID #ScienceFeed #PandemicResponse

What’s next for AVITHRAPID?
Following our meeting in Berlin , we’re entering a critical phase — improving existing antivirals while evaluating new broad-spectrum compounds.
Stronger preparedness through innovation.

#AVITHRAPID #PandemicPreparedness #OneHealth

🧪 Last 16-17 June, the #AVITHRAPID team met in Berlin to plan next steps in antiviral preparedness! Great science, strong collaboration — and a few laughs too 😄
📸 Highlights below!
#HorizonEU #DrugRepurposing #PandemicPreparedness

Our consortium partners are meeting next week in Berlin for an exciting session to exchange ideas, review progress, and plan upcoming work. Are you part of a team focused on antiviral development? Reach out to explore future collaborations with us! #AVITHRAPID #Collaboration #Innovation

The world isn’t short on brilliant science.
It’s short on collaboration, clarity, and courage.

In the face of the next crisis, how we organize knowledge may matter more than how we generate it.

We can’t afford siloed thinking anymore.
#AVITHRAPID

🚨 Highlights from #AVITHRAPID at #INFACT2025 (Naples, April 3–5)!
Harnessing Computational Power – Presented by Carmine Talarico
💻 AVITHRAPID’s in silico pipeline for antiviral targets
🧬 Applied to Dengue virus
🔍 Public workflows, docking & MD-ready models
📂 Fully open-access

🚨 Highlights from #AVITHRAPID at #INFACT2025 (Naples, April 3–5)!
Harnessing Computational Power – Presented by Carmine Talarico
💻 AVITHRAPID’s in silico pipeline for antiviral targets
🧬 Applied to Dengue virus
🔍 Public workflows, docking & MD-ready models
📂 Fully open-access